10-355(L)
MBIA Inc. V. Federal Ins. Co., et al.
UNITED STATES COURT OF APPEALS
FOR THE SECOND CIRCUIT
________________________
August Term, 2010
Argued: March 18, 2011 Decided: July 1, 2011
Docket Nos. 10-0355-cv (L); 10-0386-cv (con);
10-0356-cv (XAP)
________________________
MBIA INC.,
Plaintiff-Appellee-Cross-Appellant,
- v. –
FEDERAL INSURANCE COMPANY and
ACE AMERICAN INSURANCE COMPANY,
Defendants-Appellants-Cross-Appellees.
________________________
Before: SACK, LYNCH, Circuit Judges, and PRESKA, Chief District
Judge.*
________________________
The parties appeal and cross-appeal from a judgment
entered December 30, 2009, in the United States District Court
for the Southern District of New York (Berman, J.), granting in
part and denying in part the motion for summary judgment made by
plaintiff and granting in part and denying in part the motion for
summary judgment made by defendant insurance companies in a
breach of contract action to compel coverage for certain claims
made under directors and officers liability insurance policies.
The district court determined that plaintiff is entitled to
coverage for losses associated with federal and state regulators’
investigations of plaintiff and for losses associated with an
investigation conducted by a special litigation committee after
derivative litigation ensued. It also determined that plaintiff
is not entitled to coverage for losses associated with the cost
of an independent consultant review of two transactions. We
*
The Honorable Loretta A. Preska, of the United States District
Court for the Southern District of New York, sitting by
designation.
AFFIRM the judgment of the district court in part and REVERSE the
judgment in part and REMAND the case for entry of judgment.
________________________
ROBERT H. SHULMAN, Kasowitz, Benson,
Torres & Friedman LLP,** New York,
New York, for Plaintiff-Appellee-
Cross-Appellant.
CHRISTOPHER T. HANDMAN (David J. Hensler
and Jessica L. Ellsworth, on the
brief), Hogan Lovells US LLP,
Washington, D.C., for Defendant-
Appellant-Cross-Appellee Federal
Insurance Co.
ALAN J. JOAQUIN (Janet R. McFadden, on
the brief), Drinker Biddle & Reath
LLP, Washington, D.C., for
Defendant-Appellant-Cross-Appellee
ACE American Insurance Co.
________________________
LORETTA A. PRESKA, Chief District Judge:
This insurance coverage dispute raises three issues
arising out of financial regulators’ investigations into alleged
accounting misstatements by appellee and cross-appellant MBIA,
Inc., (“MBIA”) and related litigation. Based on these events,
MBIA made claims under two $15 million director and officer
(“D&O”) insurance policies it had purchased from appellants and
cross-appellees Federal Insurance Co. (“Federal”) and ACE
American Insurance Co. (“ACE”). It sought coverage for costs
associated with these claims as losses under the policies.
Federal and ACE did not believe they were liable for these
**
The law firm of Howery LLP originally represented MBIA, Inc.,
in this action and is named on the briefs. It dissolved as of
March 15, 2011. Christine S. Davis and Lara A. Degenhart were
listed on the brief.
2
claims, and, unsurprisingly, litigation ensued. Resolving cross-
motions for summary judgment, the district court (Berman, J.)
granted summary judgment in favor of MBIA on two of its three
coverage claims but granted summary judgment in favor of Federal
and ACE on one of MBIA’s coverage claims. We affirm in part and
reverse in part and remand a portion of the case to the district
court for entry of judgment in favor of MBIA.
I. BACKGROUND
MBIA is a Connecticut corporation based in Armonk, New
York. It provides municipalities and other government entities
with financial guarantee insurance for their bonds or structured
finance obligations; this insurance is a guarantee of payment of
principal and interest due. Like many corporations, MBIA
purchased D&O insurance coverage for its directors and officers,
as well as MBIA itself for certain claims. MBIA’s policies were
purchased from Federal and ACE for the period between February
15, 2004, and August 15, 2005, including a six-month extension.
These policies covered “Securities Claims,” which include “a
formal or informal administrative or regulatory proceeding or
inquiry commenced by the filing of a notice of charges, formal or
informal investigative order or similar document.” J.A. at 158.
The policies also cover “Securities Defense Costs,” which include
costs “incurred in defending or investigating Securities Claims.”
Id. The policies also contemplate that should MBIA seek to
invoke coverage, MBIA must give the insurers “the opportunity to
3
effectively associate . . . in the investigation, defense and
settlement” of any claim against MBIA and then seek the insurers’
consent before settling any covered claim or incurring any costs
defending such a claim. Id. at 126. Both policies included $15
million worth of coverage and covered the same claims with the
same terms and conditions except as delineated in the ACE policy.
The coverage was two-tiered: only after the Federal policy limit
was exhausted did the ACE policy provide additional coverage.
Because the two policies and claims are parallel in nearly all
respects, we will refer to Federal and ACE together as the
“insurers” throughout, analyzing the policies together except
where we note that the analysis differs with respect to one of
the insurers.
The purchases proved prescient. As part of a larger
investigation into certain accounting practices in the insurance
industry, federal and state regulators targeted MBIA in November
2004. The Securities and Exchange Commission (“SEC”) had issued
a formal order of investigation on March 9, 2001, ordering an
inquiry into certain companies’ compliance with the securities
laws, their financial recordkeeping, their financial reporting,
and related matters. Specifically, the order initiated a private
investigation into whether the subject companies “engaged, are
engaged, or are about to engage in any of the aforesaid acts,
practices, or courses of business, or in any acts, practices, or
courses of business of similar purport or object.” J.A. at 201.
4
The phrase “acts, practices, or courses of business” refers to
the allegations of financial chicanery mentioned above.
Pursuant to that investigation, the SEC issued the
first of several subpoenas to MBIA on November 12, 2004. The
subpoena did not identify specific transactions, but it compelled
MBIA to produce all documents concerning transactions involving
“Non-Traditional Product[s].” Id. at 212. These were defined
as, in relevant part,
any product or service developed, marketed,
distributed, offered, sold, or authorized for sale
. . . that could be or was used to affect the timing or
amount of revenue or expense recognized in any
particular reporting period, including without
limitation, transferring assets off of a Counter-
Party’s balance sheet, extinguishing liabilities,
avoiding charges or credits to the Counter-Party’s
financial statements, [or] deferring the recognition of
a known and quantifiable loss . . . .
Id. (emphasis added). The subpoena also required production of
MBIA’s accounting treatment of payments in connection with these
transactions and any developmental, training, or promotional
materials for them, among other things. On November 18, 2004,
the New York Attorney General (“NYAG”) followed suit and issued
its first subpoena, which mirrored the SEC’s. Others from both
the SEC and the NYAG followed through late 2004. MBIA produced
documents to both regulators in tandem.
Ultimately, three of MBIA’s transactions came under
regulatory scrutiny. The first transaction was MBIA’s purchase
of reinsurance on its guarantee of bonds issued by a hospital
group owned by Allegheny Health, Education and Research
5
Foundation (“AHERF”). MBIA insured these bonds in 1996, and
AHERF declared bankruptcy in 1998 and defaulted. Facing
approximately $170 million of exposure on its guarantee, MBIA
purchased reinsurance on the AHERF transaction whereby the
reinsurers retroactively agreed to assume MBIA’s already-realized
loss in exchange for a nominal premium. MBIA agreed to give the
reinsurers compensation in the form of future premiums from its
other financial guarantee business yet continued to assume the
risk of default on new loans guaranteed. The aim of this scheme
was to allow MBIA to avoid recognizing a large, one-time
insurance loss by disguising the loss and spreading payment for
it over a longer period of time, increasing its stated earnings.
The subpoenas caused MBIA to produce documents concerning the
AHERF transaction.
Later, in the summer of 2005, at least two other
transactions were subjected to regulatory scrutiny. The first
involved MBIA’s purchase of an interest in Capital Asset Holdings
GP, Inc. (“Capital Asset”), a company that bought delinquent tax
liens. After Capital Asset’s lender choked off funding for its
operations, MBIA provided more capital for the company. Then
MBIA, through a subsidiary, guaranteed Capital Asset’s
securitization of the liens it purchased, thereby transferring
the risk of loss on MBIA’s investment from MBIA to the
subsidiary. These machinations were designed to avoid MBIA’s
recognizing a loss on the Capital Asset deal immediately, instead
6
spreading the loss out over time because of the way the guarantee
was structured.
The second transaction involved MBIA’s guarantee of
securities used to purchase airplanes for US Airways. When US
Airways declared bankruptcy in 2002, rather than wait for a claim
on the guarantee, MBIA foreclosed on the airplanes and treated
this transaction as an “investment,” not an “insurance loss.”
Here again, MBIA took these steps to avoid recognizing a loss.
In the summer of 2005, the SEC and the NYAG considered
issuing additional subpoenas. However, in these instances, MBIA
asked the regulators whether they would accept voluntary
compliance with their demands for records in lieu of subpoenas to
avoid adverse publicity for MBIA. The regulators agreed to those
requests, and MBIA complied with their demands for documents
concerning the Capital Asset and US Airways transactions.
In May 2005, MBIA initiated the claims process by
informing the insurers that it was the target of a regulatory
investigation and by providing them with the subpoenas. MBIA
asked the insurers for their consent to retain counsel and to
incur defense costs. The insurers did not view the subpoenas as
sufficient to trigger coverage but accepted the subpoenas as
notice of a potential claim under the policies. MBIA proceeded
to hire attorneys and defend, respond to, and discuss the
regulatory inquiries.
7
Nevertheless, in August 2005, the regulators advised
MBIA that they would take action against it for securities law
violations. Apparently, discussions about settling the potential
charges were ongoing because on September 27, 2005, MBIA sought
consent from the insurers to settle with the regulators. MBIA
also met with Federal in person to discuss settlement. By letter
dated October 11, 2005, Federal responded to MBIA and said that
it understood a settlement for the AHERF transaction requiring
payment of approximately $75 million in total to state and
federal regulators was under consideration. Federal stated that
it did not believe a settlement would be covered, but it allowed
MBIA to proceed with settlement, saying that it would not “raise
the lack of its written consent to [the] settlements as a defense
to coverage.” Id. at 1044. Retroactively, ACE took essentially
the same approach in December.
MBIA signed an offer of settlement for both the state
and federal claims on October 28, 2005, but that offer was
preliminary, as the regulators had not completed their
investigation into the Capital Asset and US Airways transactions
at that time. To allow settlement talks to proceed despite this
loose end, MBIA and the regulators agreed that an independent
consultant, paid by MBIA, could complete a review of those
transactions and report on a proposed remedy if misconduct was
uncovered. MBIA first informed the insurers of this development
in September 2006. Meanwhile, the independent consultant had
8
begun work. MBIA offered an assurance of discontinuance to the
NYAG in November 2005 that would result in MBIA’s payment of a
$15 million civil penalty and $10 million in disgorgement upon
acceptance by the New York Superintendent of Insurance. By
December 2006, the SEC and MBIA reached an agreement in principle
under which MBIA would pay a $50 million civil penalty for the
AHERF transaction. Both offers of settlement to regulators
contained a provision for an independent consultant review of the
two outstanding investigations. The settlements were executed
and accepted by both regulators in late January 2007.
Ultimately, the independent consultant exonerated MBIA of any
wrongdoing for the Capital Asset and US Airways transactions.
The investigations were closed in 2007.
After these investigations came to light, lawsuits
against MBIA alleging financial wrongdoing were filed. Two
actions are relevant here, one filed in the United States
District Court for the Southern District of New York and one
filed in the New York Supreme Court. On the way to filing suit,
two shareholders sent separate demand letters to MBIA asking the
board to file suit against directors and officers for the alleged
wrongdoing being investigated by regulators at the time. In due
course, MBIA set up a committee of independent directors (the
“Demand Investigation Committee” or “DIC”) to investigate these
demands.1 MBIA did not act on the shareholder demands, which is
1
The policies contain a separate $200,000 sublimit for costs
(continued...)
9
effectively a rejection of the demand under governing Connecticut
law, but the shareholders persisted and filed two derivative
lawsuits. When the lawsuits were filed, MBIA reconstituted the
DIC as the “Special Litigation Committee” (“SLC”) to determine
whether maintaining these suits was in the best interests of
MBIA. The SLC determined, after an investigation by outside
counsel hired by the SLC, that it was not and filed a motion to
dismiss the complaints. The lawsuits were terminated.
Following all of this turmoil, Federal agreed to pay
approximately $6.4 million to cover losses from the SEC’s AHERF
transaction investigation and related lawsuits, including
$200,000 for the DIC’s investigation. But it refused to cover
losses related to the Capital Asset and US Airways transactions
and to the NYAG’s AHERF transaction investigation. Because the
Federal policy limit was not breeched, ACE paid nothing. MBIA
disagreed with the insurers’ interpretation of what the policies
covered. It filed suit to compel the insurers to cover costs
related to (1) both regulators’ investigations of all three
transactions, (2) the independent consultant’s investigation
pursuant to the settlement, and (3) the work of the SLC. The
district court granted summary judgment in favor of MBIA with
respect to costs related to the investigation of the transactions
and the costs incurred by the SLC. MBIA, Inc. v. Fed. Ins. Co.,
1
(...continued)
related to the investigation of shareholder demands. J.A. at
167. No one argues that Federal should not have applied this
limit to its coverage for costs incurred by the DIC.
10
No. 08 Civ. 4313, 2009 WL 6635307, at *7-9 (S.D.N.Y. Dec. 30,
2009). It granted summary judgment in favor of the insurers,
however, with respect to costs related to the independent
consultant’s investigation. Id. at *8-9. These appeals
followed.
II. ANALYSIS
The applicable law is straightforward. We review de
novo the district court’s grant of summary judgment. Costello v.
City of Burlington, 632 F.3d 41, 45 (2d Cir. 2011). In so doing,
we construe the facts in the light most favorable to the
nonmoving party and, drawing all reasonable inferences in its
favor, affirm when “‘there is no genuine dispute as to any
material fact and the movant is entitled to judgment as a matter
of law.’” Id. (quoting Fed. R. Civ. P. 56(a)).
In this diversity case, the issues are governed by
either New York or Connecticut state law. See Wilson v. Nw. Mut.
Ins. Co., 625 F.3d 54, 60 (2d Cir. 2010). We need not make a
choice-of-law determination because under both states’ regimes,
the applicable legal principles are aligned. An insurance
contract is interpreted under ordinary common-law contract
principles, and we “give effect to the intent of the parties as
expressed in the clear language of the contract.” Morgan Stanley
Grp., Inc. v. New Eng. Ins. Co., 225 F.3d 270, 275 (2d Cir. 2000)
(internal quotation marks omitted) (applying New York law);
11
accord Griswold v. Union Labor Life Ins. Co., 442 A.2d 920, 923
(Conn. 1982). We agree with the district court and the parties
that the contract is unambiguous, so the plain meaning of its
terms control. Cont’l Ins. Co. v. Atl. Cas. Ins. Co., 603 F.3d
169, 180 (2d Cir. 2010). In the end, the insured bears the
burden of showing that an insurance coverage covers the loss, but
the insurer bears the burden of showing that an exclusion applies
to exempt it from covering a claim. Morgan Stanley Grp., 225
F.3d at 276 & n.1. Doubts are resolved in favor of the insured.
See id. at 276.
On appeal, the insurers argue that the district court
erred in two ways. First, they argue that it erred because both
the SEC’s and the NYAG’s investigations into the Capital Asset
and US Airways transactions are not covered “Securities Claim[s]”
under the policies and because the NYAG’s investigation of the
AHERF transaction is likewise not covered. Second, they argue
that it erred because costs incurred by the SLC were either not
covered or subject to the $200,000 policy sublimit. In its
cross-appeal, MBIA argues that the district court erred in its
analysis denying it coverage for the costs of the independent
auditor. We address these arguments sequentially.
A. Investigation Costs Coverage
The insurers’ first argument involves the scope of
coverage provided in Insuring Clause 3, which states: “The
Company [i.e., the insurers] shall pay on behalf of any
12
Organization [i.e., MBIA and subsidiaries] all Securities Loss
for which it becomes legally obligated to pay on account of any
Securities Claim first made against it during the Policy Period
. . . .” A “Securities Claim” is defined as, in relevant part,
“a formal or informal administrative or regulatory proceeding or
inquiry commenced by the filing of a notice of charges, formal or
informal investigative order or similar document.” J.A. at 158.
The question here is whether the expenses claimed in connection
with the regulators’ investigations fall within this definition.2
To answer this question, we analyze the various items MBIA argues
are “Securities Claims”: the NYAG’s investigation of the AHERF
transaction and the SEC’s and the NYAG’s investigation of the
Capital Asset and US Airways transactions. We proceed in that
order.
1. The NYAG Investigation of AHERF
We agree with the district court that the NYAG’s
subpoena on the AHERF transaction was a “Securities Claim.”
Under New York law, the NYAG may commence an investigation when,
in his discretion, “he believes it to be in the public interest
that an investigation be made.” N.Y. Gen. Bus. Law § 352(1).
The outward-facing form that investigation takes is the service
of a subpoena, which, on its face, commands the production of
documents and threatens criminal penalties for noncompliance.
See, e.g., People v. Thain, 874 N.Y.S.2d 896, 899 (N.Y. Sup. Ct.
2
The parties do not dispute that the costs claimed would be
“Securities Loss[es]” as defined in the policies.
13
2009) (stating that the NYAG may require information pursuant to
the investigation and “[t]o that end, he is empowered to subpoena
witnesses” and documents (internal quotation marks omitted));
Sanborn v. Goldstein, 118 N.Y.S.2d 63, 64 (N.Y. Sup. Ct. 1952)
(stating that the NYAG “commenced an investigation pursuant to
[the Martin Act] . . . by service of a subpoena upon plaintiff”);
see also N.Y. Gen. Bus. Law § 352(4). Backed by the enforcement
authority of the state, the NYAG subpoena is at least a “similar
document” to a “formal or informal investigative order” that
commenced a regulatory proceeding, as stated in the policies.
Moreover, we agree with the district court’s sensible
intuition that a businessperson “would view a subpoena as a
‘formal or informal investigative order’ based on the common
understanding of these words.” MBIA, Inc., 2009 WL 6635307, at
*6 (internal quotation marks omitted). In any event, the
subpoena is, at absolute minimum, a “similar document” to those
listed the definition of a “Securities Claim” because it is
similar to other forms of investigative demands made by
regulators. See, e.g., ACE Am. Ins. Co. v. Ascend One Corp., 570
F. Supp. 2d 789, 796 (D. Md. 2008) (subpoenas may constitute
insurance claims when issued by a governmental investigative
agency).
We reject the insurers’ crabbed view of the nature of a
subpoena as a “mere discovery device” that is not even “similar”
to an investigative order. The New York case law makes it
14
crystalline that a subpoena is the primary investigative
implement in the NYAG’s toolshed. We also reject the insurers’
argument that because the definition does not include a
proceeding commenced by the service of a subpoena, a subpoena is
not included. This reading puts form over substance; the fact
that the definition does not say “service of a subpoena” is not
dispositive.
Because the plain-language understanding of a
“Securities Claim” includes this subpoena, “Securities Loss”
arising from this investigation is covered.
2. Capital Asset and US Airways Transactions
We now turn to whether “Securities Loss” in connection
with the Capital Asset and US Airways transactions is covered.
This determination turns on two factors: whether the SEC’s
investigation of these transactions was within the scope of its
formal order and whether the NYAG’s similar investigation was
within the scope of its AHERF investigation, which is a covered
“Securities Claim.” We begin with the SEC investigation.
a. The SEC Investigation
The text of the SEC’s formal order stated that the SEC
was empowered to investigate whether AIG and other insurance
companies, including MBIA, engaged in securities fraud,
accounting misstatements, reporting misstatements, or other
“acts, practices, or courses of business of similar purport or
object.” J.A. at 201. The district court held that the
15
investigation into these two transactions was an investigation of
a “course[] of business of similar purport or object” and, thus,
within the scope of the formal order. We agree.
As we described, the three transactions at issue here
all involved MBIA’s attempts not to report or to delay reporting
a loss. The subpoena that accompanied the formal order stated
that the SEC sought documents involving transactions designed to
“affect the timing or amount of revenue or expense recognized,”
including “extinguishing liabilities,” and “deferring the
recognition of a known and quantifiable loss.” Id. at 212.
Although the mechanics MBIA employed in each of the three
transactions differed somewhat (as we described above), there can
be no doubt that all of them involved efforts to delay, reduce,
or eliminate the reporting of a loss, precisely as described in
the subpoena. Indeed, the AHERF transaction involved an attempt
not to book a loss at all, the Capital Asset transaction involved
an attempt to spread the recognition of a loss out over time, and
the US Airways transaction involved an effort to avoid booking a
loss (and, in fact, to represent that MBIA was making an
investment in the airplanes it repossessed). These courses of
business fall within the scope of the transactions for which
documents were subpoenaed by the SEC as “Non-Traditional
Product[s].” This circumstance is highly probative of the scope
of the investigation authorized by the SEC’s formal order.
16
The formal order authorized the SEC to investigate
“any” of the broadly described acts and courses of business
listed in the formal order. Combined with the specific
definition of the items subpoenaed by the SEC, we conclude that
the plain meaning of the formal order includes these transactions
within its scope because they involved a course of business “of
similar purport or object” to that described in the formal order.
Cf. RNR Enters., Inc. v. SEC, 122 F.3d 93, 98 (2d Cir. 1997)
(concluding that a formal order predating company under
investigation included the company because of similarly inclusive
wording).
The insurers essay several reasons why they think the
formal order does not include the Capital Asset and US Airways
transactions. First, they point to the caption of the SEC’s
formal order, “In re Loss Mitigation Insurance Products,” to
argue that this phrase delimits the scope of the SEC’s
investigation to a certain sub-class of financial transactions.
This argument is unpersuasive. We do not doubt that “[t]he
purposes of such an order seem to be to define the scope of the
ensuing investigation and to establish limits within which the
staff may resort to compulsory process.” SEC v. Jerry T.
O’Brien, Inc., 467 U.S. 735, 738 n.1 (1984). But the caption
alone does not serve these functions; the whole order does. The
only place this phrase occurs is in the caption to the formal
order, and the operative language contains no limitation in scope
17
to a certain “product,” nor does it appear to contemplate such a
limitation. Instead, it announces a broad but definite
investigatory scope that includes these transactions as we
described. In this way, it is quite telling that the actual
subpoenas issued cover allegations involved in the Capital Asset
and US Airways transactions. And SEC subpoenas are enforceable
only when they request “reasonably relevant” information in
connection with the investigation. RNR Enters., 122 F.3d at 97
(quoting United States v. Morton Salt Co., 338 U.S. 632, 652
(1950)); see H.R. Rep. No. 96-1321, pt. 1, pt. 2 (1980),
reprinted in 1980 U.S.C.A.A.N. 3874, 3889. In short, the caption
to the formal order does not operate in the way advanced by the
insurers here to narrow the scope of the SEC’s investigatory
authority as set out in the text of the order. Cf. RNR Enters.,
122 F.3d at 97 (deferring to SEC’s determination of relevance in
challenge to subpoena by measuring value of information against
“general purposes of the agency’s investigation”).
The insurers next argue that these investigations were
conducted by way of oral request rather than subpoena or other
formal process. This argument is meritless. The investigation,
oral or by way of subpoena, was connected to the formal order.
The sole reason the SEC did not issue subpoenas is that MBIA
requested this procedure, and the SEC believed that MBIA would
fully comply on a voluntary basis. The insurers cannot require
that as an investigation proceeds, a company must suffer extra
18
public relations damage to avail itself of coverage a reasonable
person would think was triggered by the initial investigation.
The insurers also argue that the SEC began
investigating these transactions because it was “tipped off” by a
disenchanted investor in Capital Asset and by New York insurance
regulators questioning the US Airways transaction. Whatever the
accuracy of this assertion, we fail to see how the SEC’s
investigative source is relevant to the coverage determination.
Finally, the insurers argue that because the SEC
official who made the oral requests was not named on the formal
order, the requests were not pursuant to that order. This
argument, too, fails. The individuals named on the formal order
are empowered to compel testimony, Jerry T. O’Brien, 467 U.S. at
737-38, but the investigation authorized by the formal order need
not be pursued only by those individuals. In addition, this
policy provides coverage for “informal investigative orders,” and
the oral inquiries fit that description.3
As with the AHERF transaction, the SEC’s investigation
of the Capital Asset and US Airways transactions was commenced by
the SEC’s formal order. MBIA’s “Securities Loss” related to
3
Similar policies that have engendered litigation do not include
coverage for “informal” investigations. E.g., Capella Univ.,
Inc. v. Exec. Risk Specialty Ins. Co., 617 F.3d 1040, 1043 (8th
Cir. 2010) (coverage for “formal investigation”); Med. Mut. Ins.
Co. of Me. v. Indian Harbor Ins. Co., 583 F.3d 57, 61 n.3 (1st
Cir. 2009) (same); Cmty. Found. for Jewish Educ. v. Fed. Ins.
Co., 16 F. App’x 462, 465 (7th Cir. 2001) (unpublished) (same).
19
responding to it is therefore covered because the investigation
was pursuant to a “formal or informal investigative order.”
b. The NYAG Investigation
Our analysis of MBIA’s claim for coverage for
“Securities Loss” related to the NYAG’s investigation of the
Capital Asset and US Airways transactions proceeds similarly. By
the time the NYAG’s office began looking into these transactions,
its AHERF investigation was already underway. The NYAG’s
subpoena contained the same definition of “Non-Traditional
Product[s]” as the SEC’s subpoena, so documents relating to these
transactions were included in its scope. As with the SEC’s
investigation, MBIA requested that the NYAG issue no further
subpoenas after the AHERF subpoena, promising that MBIA would
comply fully with all demands. The NYAG agreed, like the SEC, to
this procedure and continued its investigation with oral
requests. Therefore, for the same reasons that “Securities Loss”
related to the SEC’s investigation into the Capital Asset and US
Airways transactions is covered, such loss related to the NYAG’s
investigation into these transactions also is covered.
3. Summary
For the reasons stated above, MBIA’s “Securities Loss”
related to (1) the NYAG’s investigation into the AHERF
transaction and (2) both the SEC’s and the NYAG’s investigations
into the Capital Asset and US Airways transactions is covered
under the policy. Each of the investigations was commenced by a
20
“formal or informal investigative order or similar document” and
is therefore a “Securities Claim.”
B. Derivative Litigation Coverage
Turning to the insurers’ second contention, the costs
incurred by the SLC in terminating the derivative litigation were
covered “Defense Costs” (or “Securities Defense Costs”) under the
policies. The policies provide coverage (under Insuring Clauses
2 and/or 3) to MBIA and/or its directors for expenses incurred in
defending or investigating claims (including “Securities
Claims”). J.A. at 131, 158. A claim includes a lawsuit. Id.
The insurers argue that the SLC-related costs are not
covered for three main reasons. First, they say that the costs
were incurred by the SLC (and not MBIA or any individual
directors) and that the SLC is not an “Insured Person.”4 Second,
they focus on the nature of a derivative suit to say that
granting MBIA coverage for the SLC’s role would render the
$200,000 sublimit for demand investigation costs superfluous.
See supra note 1. Third, they rely on exclusions from the
definition of “Loss.” We conclude that the costs are covered.
We begin with the anatomy of a derivative action.
Connecticut law applies here because the suits alleged state
claims against MBIA, a Connecticut corporation. Halebian v.
4
An “Insured Person” is defined as “any past, present or future
duly elected director or duly elected or appointed officer of
[MBIA].” J.A. at 131. The definition also includes MBIA itself
in providing coverage for “Securities Loss.” Id. at 157-58.
21
Berv, 590 F.3d 195, 206 (2d Cir. 2009); May v. Coffey, 967 A.2d
495, 501 n.6 (Conn. 2009). In Connecticut, shareholders must
perform two distinct steps to initiate a derivative suit. See
Stutz v. Shepard, 901 A.2d 33, 36 n.5 (Conn. 2006). First, a
disenchanted shareholder must make a demand on the corporation
“to take suitable action.”5 Conn. Gen. Stat. Ann. § 33-722.
Then, after one of three events, the shareholder may commence a
derivative suit: (1) the passing of ninety days without any
action by the corporation, (2) notification that the
shareholder’s demand is rejected, or (3) a showing that
irreparable injury would follow if the court waited for the
ninety-day period to expire. Id.
Connecticut law also provides that a corporation may
form a committee of independent directors to determine whether
maintaining a derivative action is in the best interests of the
corporation. Id. §§ 33-605, 33-724; Frank v. LoVetere, 363 F.
Supp. 2d 327, 333 (D. Conn. 2005). If that committee determines
“in good faith, after conducting a reasonable inquiry upon which
its conclusions are based,” that maintaining the suit is not in
the best interests of the corporation, it has the authority to
move for dismissal. Conn. Gen. Stat. Ann. § 33-724(a). On such
a motion, the court “shall” dismiss the lawsuit. Id.
5
Because this case involves a situation where demands were made
on the board, we do not address demand futility. See Joy v.
North, 692 F.2d 880, 887-88 (2d Cir. 1982); Sheehy v. Barry, 89
A. 259, 261 (Conn. 1914).
22
Here, both shareholders followed the two-step process
and made a demand before filing suit. Ultimately, after the DIC
performed its work, MBIA did not act within the ninety-day period
provided by Connecticut law. Thereafter, the shareholders took
the next step and filed lawsuits. MBIA formed the SLC to
determine MBIA’s response to this litigation, and the SLC decided
to terminate the litigation. The SLC entered appearances for
MBIA and filed motions to dismiss on its behalf in both the state
and federal cases. The federal suit was voluntarily dismissed
pursuant to Rule 41 of the Rules of Civil Procedure before the
court could rule on it; the parties do not dispute that the state
court action was also terminated, although the record does not
indicate in precisely what manner.
Connecticut law allows this procedure. The board may
terminate derivative litigation by a majority vote of either of
two sub-units of the board: (1) the independent directors if they
constitute a quorum or (2) a committee composed of at least two
independent directors. Id. §§ 33-605, 33-724(b). “A
corporation, possessing an identity only in a legal sense,” can
act only through its agents. In re Payroll Express Corp., 186
F.3d 196, 207 (2d Cir. 1999). That Connecticut law permits the
board to terminate a derivative suit is an extension of the
fundamental principle that the management and ownership of a
corporation are divided, with management undertaken by the board.
Conn. Gen. Stat. Ann. § 33-735(b). In other words, corporate
23
powers and management are exercised by agents “under the
authority of” or “under the direction of” the board. Id. The
SLC was one way MBIA exercised its powers. See, e.g., id. § 33-
724(a); Zapata Corp. v. Maldonado, 430 A.2d 779, 785 (Del. 1981)
(“[A]n independent committee possesses the corporate power to
seek the termination of a derivative suit.”); Revised Model Bus.
Corp. Act § 7.44 official cmt. (citing Aronson v. Lewis, 473 A.2d
805, 813 (Del. 1984), overruled on other grounds by Brehm v.
Eisner, 746 A.2d 244 (Del. 2000)).6
Dismissal of the suits was MBIA’s decision, undertaken
pursuant to the powers granted to MBIA under Connecticut law,
Conn. Gen. Stat. Ann. § 33-724(a), and exercised by the SLC as
permitted under Connecticut law, id. § 33-724(b)(2). See also
Aronson, 473 A.2d at 813 (stating that, ultimately, the board
“retains its . . . managerial authority to make decisions
regarding corporate litigation”). We thus reject the insurers’
suggestion that the SLC was not an “Insured Person.”
6
Because Connecticut law on certain derivative litigation issues
is not particularly well developed, Frank, 363 F. Supp. 2d at
334, we look to the Revised Model Business Corporations Act
(“RMBCA”), on which the Connecticut statute is based, and
Delaware law to elucidate fundamental principles, not substantive
rules, because those principles bear on these issues. We are
aware that Delaware law does not control and do not in any way
suggest that it supplies the rule of decision. May, 967 A.2d at
501 n.6. Nevertheless, Delaware jurisprudence is useful in
discussing general principles. RMBCA § 7.44 official cmt., pt. 2
(stating that the relevant section of the statute “is similar in
several respects . . . to the law as it has developed in
Delaware” but noting certain procedural differences).
24
To counter this reasoning, the insurers argue that the
SLC was required to operate independently of MBIA. They
postulate that this circumstance means that the SLC took on an
identity and exercised powers separate and apart from those
granted to MBIA. This is argument by sleight of hand.
Connecticut law — and corporation law generally — requires that
the decision to proceed with or terminate derivative litigation
be made by independent directors to satisfy their fiduciary
duties. Conn. Gen. Stat. Ann. § 33-724(a)-(b); see, e.g.,
Aronson, 473 A.2d at 811-12, 814. “Independent” in this context
means independence of judgment — a lack of conflicts of interest.
See Conn. Gen. Stat. Ann. § 33-605; Frank, 363 F. Supp. 2d at
333; see also RMBCA § 1.43 official cmt. (stating that such
directors must be “disinterested” and “independent” so as to
avoid a “likelihood that that director’s objectivity will be
impaired”). Independence of judgment does not generate a new
source of authority to terminate derivative litigation; that
authority is still exercised by the corporation, which can act
only through its agents. Aronson, 473 A.2d at 813; see Conn.
Gen. Stat. Ann. § 33-724(a)-(b); Frank, 363 F. Supp. 2d at 333,
335 (“[A] corporation should be free to determine in its own
business judgment whether litigation is in its best interest
. . . .”). We do not agree with the insurers’ characterization
of the SLC’s “independence.”
25
The insurers’ second argument relies on the nature of a
derivative suit. Relying on the precept that an interpretation
rendering a contract term superfluous is “disfavor[ed],” Int’l
Multifoods Corp. v. Comm’l Union Ins. Co., 309 F.3d 76, 86 (2d
Cir. 2002), the insurers say that because the SLC investigates
whether to maintain a derivative suit, coverage of the SLC’s
costs would eviscerate the sublimit applicable to the
investigation of shareholder demands. We disagree.
The $200,000 sublimit provides that the insurers’
“maximum liability for all Investigation Costs covered under
Insuring Clause 4 on account of all Shareholder Derivative
Demands . . . shall be $200,000.” J.A. at 167. Insuring Clause
4 states:
The [insurer] shall pay on behalf of [MBIA] all
Investigation Costs which [MBIA] becomes legally
obligated to pay on account of any Shareholder
Derivative Demand first made during the Policy Period
. . . for a Wrongful Act committed, attempted, or
allegedly committed or attempted, by an Insured Person
before or during the Policy Period.
Id.
In this instance, the insurers’ argument requires that
the $200,000 sublimit operate as an exclusion of coverage. They
therefore “bear[] the burden of proving that the claim falls
within the scope of an exclusion.” Vill. of Sylvan Beach v.
Travelers Indem. Co., 55 F.3d 114, 115 (2d Cir. 1995) (citing
Maurice Goldman & Sons, Inc. v. Hanover Ins. Co., 607 N.E.2d 792,
793 (N.Y. 1992)). To do so, the insurers must show that the
26
policies, in “clear and unmistakable language,” exclude coverage.
Id. (internal quotation marks omitted). Bearing in mind that we
must read a contract “as a whole” and construe terms in context,
Law Debenture Trust Co. of N.Y. v. Maverick Tube Corp., 595 F.3d
458, 467-68 (2d Cir. 2010), we conclude that the insurers do not
meet this burden.
The policies’ structure and terms track the statutory
shareholder grievance process. Insuring Clause 4, with its
concomitant $200,000 sublimit, by its terms applies to costs
related to investigating “Shareholder Derivative Demands,” which
involves the first step in Connecticut’s regime. But when a
demand is rejected and the shareholders file a derivative suit in
court, the application of Insuring Clause 4 to further
investigative costs is less obvious. At best, to cover such
costs, the language “on account of any Shareholder Derivative
Demand” would have to be expanded to include the second stage of
the Connecticut process, a lawsuit. At that stage, however,
Insuring Clause 2 or 3 squarely applies because both provide
coverage for costs “incurred in . . . investigating” “Claims” or
“Securities Claims,” respectively, each of which is defined
expressly to include lawsuits. J.A. at 131, 158. Thus, either
or both of Insuring Clauses 2 and/or 3 certainly provide coverage
at the lawsuit stage. This view of the policies makes sense
because their structure and terms mirror the two-stage
shareholder grievance process of the Connecticut statute:
27
Insuring Clause 4 specifically references a shareholder
derivative demand, while Insuring Clauses 2 and 3 specifically
reference lawsuits.7 Irrespective of whether the language of
Insuring Clause 4 bridges the gap between the demand stage and
the litigation stage of a shareholder grievance — a question on
which we take no view — we find certainty in saying only that the
insurers have not met their heavy burden to show that the
exclusion, as it operates here, applies.
Finally, the insurers attempt to rely on the policies’
exclusion of “any amount incurred by [MBIA] (including its board
of directors or any committee of the board of directors) in
connection with the investigation or evaluation of any Claim or
potential Claim by or on behalf of [MBIA]” from the definition of
“Loss.” J.A. at 144. Here, the insurers bear the burden to
“establish that the exclusion is stated in clear and unmistakable
language, is subject to no other reasonable interpretation, and
applies in the particular case.” Cont’l Cas. Co. v. Rapid-Am.
Corp., 609 N.E.2d 506, 512 (N.Y. 1993). The insurers do not
carry this heavy burden in this case.
7
The formation of an SLC is far from an aberration. E.g.,
Strougo v. Bassini, 282 F.3d 162, 167 n.3 (2d Cir. 2002) (SLC
formed to investigate shareholder derivative suit); Stutz, 901
A.2d at 37 (same); In re Comverse Tech., Inc., 866 N.Y.S.2d 10,
17 (N.Y. App. Div. 2008) (same); see also, e.g., In re Am. Int’l
Grp. Inc. Consol. Derivative Litig., 976 A.2d 872, 881 n.13 (Del.
Ch. 2009) (same). The insurers know how corporations evaluate
derivative litigation and could have written the contract to
contemplate exactly this situation. Indeed, the specific
attention given in the policies to the demand investigation
portion of this process suggests that the parties knew how to
contract about costs related to the SLC.
28
To avail themselves of this exclusion, the insurers
primarily rely on the procedural fact that MBIA is a plaintiff in
the caption of the cases because the lawsuits, which are
“Claims,” were filed “on behalf of” MBIA. But MBIA is named as a
nominal defendant in the caption of these derivative actions as
well. This situation is unsurprising because, in a derivative
suit, the “corporation is in an anomalous position of being both
a defendant and a plaintiff in the same action.”8 Ma'Ayergi &
Assocs., LLC v. Pro Search, Inc., 974 A.2d 724, 728 (Conn. App.
Ct. 2009). Thus, the insurers’ reliance on the “on behalf of”
language provides only equivocal support for their position.
Moreover, we think that the exclusion in the definition of “Loss”
is not clearly applicable to the costs incurred by the SLC
because those costs were, at least to some extent, related to
litigation, not investigation. In sum, we are not persuaded that
MBIA has carried its burden to show that this exclusion applies.
The costs incurred by the SLC are covered under the
policies.
C. Independent Consultant Coverage
The final issue remaining is whether the costs of the
independent consultant are covered. MBIA informed the insurers
in September 2005 of settlement discussions requiring payment of
8
This awkward procedural posture is an accident of history. The
derivative suit evolved from equity, where two suits were
brought, one against the corporation to compel action and the
other against the individual officers and directors for alleged
malfeasance. This procedure evolved into a single action. See
generally Ross v. Bernhard, 396 U.S. 531, 537-39 (1970).
29
approximately $75 million in disgorgement and penalties. Because
the regulators had not completed their investigation into the
Capital Asset and US Airways transactions, in October 2005, they
asked MBIA to add an independent consultant (“IC”) review of
those transactions as a condition of any settlement. MBIA would
pay for this review, which increased the costs of the total
settlement. While MBIA made settlement overtures during this
time, settlement itself remained tentative.
The IC began work in mid-2006, and the insurers were
first notified of the addition of the IC in September 2006. In
October 2006, the insurers and MBIA again discussed settlement
proposals under consideration, including the regulators’
insistence on an IC review. On December 6, 2006, MBIA sent the
insurers copies of its settlement offer. Any settlement was
still unconsummated.
Then, on December 15, 2006, MBIA gave the regulators
its final offer of settlement, which the regulators accepted in
late January 2007. The SEC issued a cease-and-desist order on
January 29, 2007, and the NYAG finalized an assurance of
discontinuance with MBIA on January 25, 2007. These events
marked a final settlement, and MBIA reported the investigations
and settlements to the public shortly thereafter. MBIA Inc.,
Current Report (Form 8-K) (Jan. 31, 2007). In July 2007, the IC
issued a report exonerating MBIA from wrongdoing with respect to
30
the Capital Asset and US Airways transactions. This event
officially ended the regulators’ investigations.
The district court held that the addition of the IC in
the course of settlement discussions breached the “right to
associate” clause in the policies and that IC-related costs are
therefore not covered. MBIA, Inc., 2009 WL 6635307, at *8-9.
Having considered the parties’ nuanced and multifaceted arguments
on appeal, we appreciate the difficult question the district
court faced on this point. Ultimately, however, we take a
different view and conclude that the IC costs were covered.
We begin with the “right to associate” clause, which
states in Federal’s policy:
[Federal] shall have the right and shall be given the
opportunity to effectively associate with [MBIA] in the
investigation, defense and settlement, including but
not limited to the negotiation of a settlement, of any
Claim that appears reasonably likely to be covered in
whole or in part by this Policy.
J.A. at 126. ACE’s policy contains similar language: “[ACE]
shall have the right, but not the duty, and shall be given the
opportunity to effectively associate with the insureds in the
investigation, settlement or defense of any Claim, even if
[Federal’s] Underlying Limit has not been exhausted.” Id. at
188. As the policy language indicates, these policies required
MBIA to give the insurers the opportunity to associate in
settlement discussions.
MBIA argues that it notified the insurers of a proposed
settlement and invited them to associate, in compliance with both
31
“right to associate” clauses, by its September 27, 2005, letter
seeking consent to settle the regulators’ investigations.9 See
J.A. at 400, 1042, 1091, 1097. MBIA also points to settlement
discussions with the insurers throughout the settlement offer
process as indications that it complied with the “right to
associate” clause. The insurers counter that although MBIA
informed them of a proposed settlement of $75 million, it
breached the “right to associate” clause when it failed to inform
them until September 2006 of the addition of the IC to the
settlement proposals.
The purpose of the “right to associate” clause is to
provide the insurer with an “option to intervene” in the defense
and settlement of a claim. See Mut. Ins. Co. v. Murphy, 630 F.
Supp. 2d 158, 166-67 (D. Mass. 2009); see also Christiania Gen.
Ins. Corp. of N.Y. v. Great Am. Ins. Co., 979 F.2d 268, 277 (2d
Cir. 1992) (describing right to associate as “opportunity”);
Outboard Marine Corp. v. Liberty Mut. Ins. Co., 536 F.2d 730, 736
(7th Cir. 1976) (describing right to associate as an “option”).
To “associate” means to “come together as partners . . . or
allies.” Webster’s Third New International Dictionary 132
(1986). This right thus allows the insured and the insurer to
come together as partners in investigating, defending, or
settling a claim. That partnership can be useful to an insured,
9
We note that in an otherwise well-briefed appeal, no party put
this quite relevant letter into the record. We must rely on
inferences from e-mail correspondence referencing and sending the
letter and the insurers’ responses to it.
32
who may lack the expertise and experience of an insurer, where,
as here, the insured bears the duty to defend. See Outboard
Marine, 536 F.2d at 736.
Of course, providing the insurer with sufficient notice
of the claim allows it to meaningfully exercise its option. See
Christiania, 979 F.2d at 277. However, the right to associate is
useful only if the insurer can use its experience throughout the
process, not just at the end stages. The policies read as such.
They provide, in the present tense, for an “opportunity to
effectively associate with [the insured] in the investigation,
defense and settlement” of a claim. J.A. at 126. Indeed, the
Federal policy underscores this point by stating explicitly that
the right to associate applies to “the negotiation of a
settlement.” Id.
These principles lead us to conclude that MBIA
fulfilled its obligations under the policies’ “right to
associate” clauses. It provided sufficient notice of the claims
involved in settlement discussions early enough in the process to
allow the insurers to exercise their option to associate
effectively. Where the insured gives the insurer an invitation
to associate with adequate information about the claim under
consideration for settlement, the insured has done what is
required under this clause. This is not to say that the right to
associate is a one-shot opportunity, but it is not the insured’s
duty to return to the nonparticipating insurer each time
33
negotiations about the same claim take a new twist and ask if the
insurer still wants to opt out. In short, the insured can take
the insurer’s RSVP at face value.
That is what MBIA did here. It gave the insurers an
opportunity to join with it in resolving the regulators’
investigations, but the insurers declined to participate. To
give the insurers the opportunity to exercise their right
effectively, as it must, MBIA notified the insurers of a
potential claim long before settlement was discussed. It
informed the insurers of the nature of the claims and provided an
estimate of the monetary amount of those claims. It also met
with Federal in person to discuss possible settlements. After
the insurers declined to participate in settlement negotiations,
MBIA proceeded to negotiate settlements itself.
As it turned out, the settlements exceeded MBIA’s $75
million estimate and included a different type of costs in the
form of IC expenses, as opposed to merely disgorgement and
penalties provided in the settlement offers. But the IC review
was not a standalone or separate claim about which MBIA had to
invite the insurers to associate in defending or negotiating. It
was part of the settlement with the regulators, each of which
conducted a single, comprehensive investigation into all of the
transactions at issue, as explained supra in Part II.A. The IC
review component grew out of the natural course of settlement
discussions about the same claim in which the insurers could have
34
participated all along. The addition of the IC may have been a
twist in settlement discussions, but it was not a new claim, nor
was it an unforeseeable component of the settlement discussions.
MBIA illustrates this reality by pointing out that ICs are not a
rare component of regulatory settlements with securities
regulators, so the insurers, which have extensive experience with
other policyholder claims, should not have been “blindsided” when
they found out that the settlements included such a component.
See Schwartz v. Liberty Mut. Ins. Co., 539 F.3d 135, 146 (2d Cir.
2008). And although the insurers argue that MBIA signed
settlement agreements containing an IC review in October 2005,
the fact remains that any offer of settlement made in October
2005 was preliminary; no settlement was consummated until the
regulators approved it, which both the state and federal
regulators did in January 2007, well after the insurers learned
of the IC component.10 Finally, even at the time they were first
notified of the IC in September 2006, the insurers made no
10
We acknowledge Federal’s argument that because the initial
settlement proposals were signed before the insurers were
informed of the IC, the insurers were presented with a fait
accompli when they were informed of the IC component as part of a
final settlement. Whatever the practical reality of this
argument (an issue on which we take no view), MBIA nevertheless
gave the insurers sufficient notice about the claims involved and
the order of magnitude of any potential settlement, yet the
insurers never attempted to join in settlement discussions.
Thus, under the association clause, MBIA fulfilled its duties.
That the information MBIA gave the insurers in October 2005 may
not have been perfect in hindsight has no legal import because
the insurers were given the opportunity to associate. In any
event, the insurers also had the opportunity to withhold consent
from any settlement but failed to do so, as we explain below.
35
overtures to become involved in the settlement process. They
cannot now argue that they were denied their rights under the
“right to associate” clause.
Because MBIA gave the insurers the opportunity to
exercise meaningfully their option to participate in settlement
discussions and adequately informed them of the nature and amount
of claims under consideration for settlement, it did not breach
its contractual obligation under the association clause.
Notwithstanding this conclusion, the insurers argue
that a settlement including an IC review exceeded the bounds of
the insurers’ agreement not to raise consent to settlement as a
defense to coverage. The insurers argue that they agreed to
waive this defense only for the $75 million settlement of the
AHERF investigation, which they were informed about in October
2005. MBIA disagrees, saying that the insurers gave it
unconditional authority to settle. It also argues that the
insurers were seasonably informed of the IC component of the
settlement offers so as to voice any objection before the
settlements were completed.
The insurers’ argument is rooted in the “right to
consent” clause in the policies, which states that MBIA will not
“agree not to settle any Claim, incur any Defense Costs or
otherwise assume any contractual obligation or admit any
liability with respect to any Claim without [the insurer’s]
36
written consent, which shall not be unreasonably withheld.”11
J.A. at 126.
“A consent clause entitles an insurer ‘to notice of a
proposed settlement and an opportunity to determine, before the
settlement, whether it will grant or withhold consent.’”
Schwartz, 539 F.3d at 145 (quoting Travelers Indem. Co. v.
Eitapence, 924 F.2d 48, 50 (2d Cir. 1991)). Whether notification
is sufficient depends on the circumstances. See id. at 146-47;
Eitapence, 924 F.2d at 50; State Farm Auto. Ins. Co. v. Blanco,
617 N.Y.S.2d 898, 899 (N.Y. App. Div. 1994). By an insurer’s
unreasonable delay, silence, or conduct, it can either waive a
consent requirement or acquiesce in a settlement. E.g., Blanco,
617 N.Y.S.2d at 899; see also Jones Lang Wootton USA v. LeBoeuf,
Lamb, Greene & MacRae, 674 N.Y.S.2d 280, 287-88 (N.Y. App. Div.
1998).
There is no doubt that MBIA informed the insurers about
the $75 million proposed settlement with the regulators for the
AHERF investigation; Federal and ACE each acknowledged that
figure in responding to MBIA’s request for permission to settle.
J.A. at 1042-44, 1096-1100. In their letters, the insurers
agreed not to raise their lack of written consent as a defense to
11
In its brief, MBIA seems to suggest that ACE’s policy does not
include Federal’s right to consent. ACE’s policy incorporates
the “terms, definitions, conditions, exclusions and limitations
of the [Federal policy], except as otherwise provided [in the ACE
policy].” J.A. at 187. The ACE policy is silent with respect to
the right to consent, so we do not consider the policies as
different in this regard.
37
coverage for those settlements — which the insurers carefully
described as disgorgement and penalties related to the AHERF
transaction. The waiver of a no-consent defense was not, as MBIA
urges, unconditional. Thus, the question becomes whether,
subsequent to the October 2005 settlement discussions, MBIA
sufficiently notified the insurers of the addition of the IC to
the settlement so as to allow them to withhold consent. We
conclude that MBIA provided sufficient notification.
To begin, MBIA informed the insurers that any
settlement proposal was subject to change. Although MBIA did not
inform the insurers about the IC until September 2006, it did so
then, in October 2006, and in a December 6, 2006, letter
containing copies of its final proposed offer of settlement. The
offer of settlement was sent to the regulators on December 15,
2006, and not accepted until the end of January 2007. These
various notifications to the insurers were enough to allow them
“determine, before the settlement, whether [they] will grant or
withhold consent.” Schwartz, 539 F.3d at 145. In Schwartz, we
held that a jury could find that eleven hours of notice
(overnight) was sufficient to satisfy a similar consent
provision. See id. at 145-47. To be sure, Schwartz involved a
situation where the insurer was deeply involved in settlement
discussions and monitoring, so the eleven-hour time period in
that case may have been enough because of the peculiar
circumstances present there. See id. Thus, while we do not in
38
any way suggest that notification must meet a temporal bright
line, we hold that in these particular circumstances, MBIA
notified the insurers about the IC with more than sufficient time
to digest the information under any conceivable standard. We
explain briefly.
Even if we assume that the December 6 letter was the
notification and the December 15 date was the time beyond which
the settlement was no longer subject to change or objection, the
insurers had over a week to decide whether to voice an objection
or lack of consent. They had been informed of the nature of the
claims to be settled and had solid indications of the dollar
amount of those claims. Moreover, the insurers participated in
at least two meetings with MBIA in September and October 2006 to
discuss settlement proposals, including the possibility of an IC
review. However, after no meeting or letter notice did the
insurers do anything or voice any objection. Nor have they
provided any explanation for their inaction. Given these facts,
we conclude that MBIA provided sufficient notice of the IC
component of the settlement. The insurers’ agreement to waive
lack of consent to settlement in 2005 was, by their silence and
inaction, reasonably perceived by MBIA to be a continuing waiver
of that defense as they learned more about the contours of the
final settlement being considered, without expressing any
objection to the additional provisions of the evolving
settlement. See, e.g., Blanco, 617 N.Y.S.2d at 899 (acquiescence
39
in settlement or waiver of prior consent provision indicated by
silence, insurer conduct, or unreasonable delay). Although it
may belabor the point, we note that the ultimate settlement arose
from a single claim, see supra Part II.A., and included elements
that grew out of a single course of settlement discussions, see
supra Part II.C. Given that the insurers were notified about the
IC and did not object, MBIA was entitled in this case to presume
that the insurers would not raise lack of written consent as a
defense to coverage with respect to the IC costs.
Before we conclude, there is one loose end. The
insurers argue that the Assurance of Discontinuance (“AOD”)
entered into with state regulators precludes coverage of IC-
related costs. The district court did not consider this
argument. “Ordinarily, we will not review an issue the district
court did not decide. However, whether we do so or not is a
matter within our discretion.” Colavito v. N.Y. Organ Donor
Network, Inc., 486 F.3d 78, 80 (2d Cir. 2007) (Sack, J.)
(internal quotation marks and citations omitted). Mindful that
“[w]e review a grant of summary judgment de novo applying the
same standard as the district court,” Graham v. Long Island
R.R., 230 F.3d 34, 38 (2d Cir. 2000), we exercise our discretion
in this case to consider this argument in the first instance in
order to minimize inefficiency and conserve judicial resources.
This question is a pure matter of contract interpretation, and no
facts are in dispute. Contracts are construed to give the
40
intention of the parties effect, so an unambiguous contract “must
be enforced according to the plain meaning of its terms.” Cont’l
Ins. Co., 603 F.3d at 180 (internal quotation marks omitted). If
we find, as we do here, that the contract is unambiguous, we “may
then award summary judgment.” Int’l Multifoods Corp., 309 F.3d
at 83 (internal quotation marks omitted).
The AOD says in the section outlining the $25 million
in disgorgement and civil penalties: “MBIA agrees that it shall
not . . . seek or accept, directly or indirectly, reimbursement
or indemnification, including, but not limited to, payment made
pursuant to any insurance policy, with regard to any or all of
the amounts payable pursuant to this Assurance.” J.A. at 338-39.
The AOD then, in a separate section, goes on for six pages to
discuss the requirements of the IC review, for which MBIA agreed
to pay, with no limitation on MBIA’s ability to seek or obtain
reimbursement. That section states that the IC’s “compensation
and expenses shall be borne exclusively by MBIA, and shall not be
deducted from any amount due under the provisions of this
Assurance.” Id. at 344.
The plain terms of the AOD fix the limitation on
reimbursement to “amounts” due under the AOD. An “amount” is the
“sum total to which anything mounts up or reaches” in “number” or
“quantity.” 1 Oxford English Dictionary 411 (2d ed. 1989).
“Amounts” relate here to the “amounts” laid out in the contract:
$10 million in disgorgement and $15 million in civil penalties,
41
not to unspecified “compensation and expenses” incurred by an IC.
Moreover, IC-related expenses necessarily are not a set “amount”
due because the IC, at the time the agreement was signed, was set
to do work in the future. Finally, the AOD itself distinguishes
IC expenses from any “amount” due under the AOD when it says that
IC expenses may not be deduced from the “any amount due.” It
also contains two separate sections dealing with separate topics
— first, a monetary payment amount for disgorgement and civil
penalty and, second, an open-ended commitment to engage the IC to
determine whether MBIA engaged in misconduct — but the
reimbursement limitation appears only in the first section.
Given the terms of the AOD and its structure, we
conclude that the AOD does not preclude MBIA’s seeking
reimbursement for IC-related costs. Although it merely confirms
our conclusion, it is instructive that the IC ultimately
determined that MBIA did not engage in misconduct with respect to
the Capital Asset and US Airways transactions. If the IC had
concluded otherwise, liability would have been outstanding under
the AOD, and any agreement as to payment for such liability could
have included a restriction on MBIA’s ability to obtain
reimbursement.
Absent a prohibition on obtaining reimbursement for
these costs, MBIA may seek coverage for them. Indeed, MBIA is
entitled to coverage for costs related to the IC’s review because
the IC investigation was a covered investigation cost under the
42
policies. The IC component was a thorough investigation of the
claims relating to the Capital Asset and US Airways transactions
and falls within the definition of “Investigation Costs” under
the policies.
III. CONCLUSION
For the reasons elucidated above, we agree with the
conclusions reached by the district court with respect to
coverage for all costs except those related to the independent
consultant. The judgment of the district court therefore is
affirmed in part and reversed in part. We remand the case to the
district court for entry of judgment in favor of MBIA on its
claim for coverage of the independent consultant’s costs. The
parties shall bear their own costs.
43